Celsius (NASDAQ:CELH) PT Lowered to $26.00 at Bank of America

Celsius (NASDAQ:CELHFree Report) had its price objective trimmed by Bank of America from $32.00 to $26.00 in a research report sent to investors on Thursday morning, Benzinga reports. The firm currently has an underperform rating on the stock.

CELH has been the topic of several other reports. Roth Mkm reduced their price objective on Celsius from $65.00 to $45.00 and set a buy rating on the stock in a research note on Thursday. TD Cowen cut their price target on shares of Celsius from $68.00 to $50.00 and set a buy rating on the stock in a report on Wednesday, August 7th. Jefferies Financial Group reduced their price target on Celsius from $68.00 to $53.00 and set a buy rating on the stock in a report on Thursday. Morgan Stanley restated an equal weight rating and set a $50.00 price objective on shares of Celsius in a report on Tuesday, August 20th. Finally, Stifel Nicolaus cut their price target on shares of Celsius from $61.00 to $51.00 and set a buy rating on the stock in a report on Thursday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and a consensus target price of $57.64.

Read Our Latest Report on Celsius

Celsius Stock Down 0.2 %

NASDAQ CELH opened at $31.96 on Thursday. The firm has a market capitalization of $7.45 billion, a P/E ratio of 35.12, a PEG ratio of 1.57 and a beta of 1.90. The company has a 50-day moving average price of $45.15 and a 200-day moving average price of $66.48. Celsius has a 52 week low of $31.55 and a 52 week high of $99.62.

Celsius (NASDAQ:CELHGet Free Report) last released its earnings results on Tuesday, August 6th. The company reported $0.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.23 by $0.05. Celsius had a net margin of 19.58% and a return on equity of 94.75%. The company had revenue of $402.00 million during the quarter, compared to analyst estimates of $391.07 million. During the same period in the prior year, the firm posted $0.17 EPS. The firm’s quarterly revenue was up 23.4% compared to the same quarter last year. As a group, equities research analysts anticipate that Celsius will post 1 EPS for the current year.

Hedge Funds Weigh In On Celsius

Several institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its holdings in Celsius by 18.7% during the first quarter. Vanguard Group Inc. now owns 16,313,762 shares of the company’s stock worth $1,352,737,000 after buying an additional 2,567,290 shares in the last quarter. Capital International Investors grew its position in shares of Celsius by 50.6% during the 1st quarter. Capital International Investors now owns 3,966,194 shares of the company’s stock valued at $328,877,000 after acquiring an additional 1,333,217 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Celsius by 231.2% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,946,208 shares of the company’s stock valued at $225,289,000 after purchasing an additional 2,754,722 shares in the last quarter. Wellington Management Group LLP raised its holdings in Celsius by 212.2% in the 4th quarter. Wellington Management Group LLP now owns 3,393,586 shares of the company’s stock worth $185,018,000 after purchasing an additional 2,306,598 shares during the period. Finally, Eagle Asset Management Inc. boosted its position in Celsius by 188.8% during the fourth quarter. Eagle Asset Management Inc. now owns 2,958,771 shares of the company’s stock worth $161,312,000 after purchasing an additional 1,934,400 shares in the last quarter. Institutional investors and hedge funds own 60.95% of the company’s stock.

About Celsius

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Featured Stories

Analyst Recommendations for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.